Skip to main content

Posts

Samyra vs. Old Navy & Cardi B ( round 2)

 Samyra vs. Old Navy & Cardi B ( round 2)  Samyra is back trending for her plus size inclusive advocacy. As usual she’s rubbing people the wrong way with her antics. She’s targeting Cardi B again with a post questing why Old Navy would collab with her. This got the internet talking so Cardi b makes a response questing why Samyra is messing with her money. Of course the internet is talking. Some praising Samyra for continuing to fight the good fight but some are questioning her motives especially after she dropped a dissed track that some have called out for being a copy and a repeat tactic. Some are calling out the cycle of calling out brands and then hiding from the internet, while having her mom come on the internet while she gets in the booth to make a diss track or shoot a music video. Some people have recognized that Samyra is very talented and truly just wants to do music but relies on social media antics to get noticed. In this video I break down everything. What do...
Recent posts

When the Music Stops: Lizzo, Public Perception, and the High Cost of Reinvention

When the Music Stops: Lizzo, Public Perception, and the High Cost of Reinvention By Phatabulous Magazine For several years, Lizzo represented something much bigger than music. She became a cultural symbol of body confidence, joy, self-acceptance, and unapologetic authenticity. Her chart-topping hits, Grammy Awards, and infectious personality made her one of the most recognizable entertainers of the last decade. Today, however, the conversation surrounding the superstar has shifted. Following the release of her latest album, Bitch , Lizzo has found herself confronting one of the biggest professional disappointments of her career. The album reportedly sold fewer than 3,000 units in its first week, failed to debut on the Billboard 200, and experienced a steep decline in its second week. In a recent interview with Zachary Hourihane, Lizzo admitted that those numbers were “soul-crushing,” revealing that she briefly allowed commercial performance to define her self-worth before reminding her...

Why Mo’Nique Won’t “Just Get Over It” | The Untold Story Behind Her Open Letter

Mother Wounds & Public Battles: What Mo’Nique’s Open Letter Reveals About Healing, Hurt, and the Weight of Women’s Relationships When comedian and actress Mo’Nique publicly addressed Whoopi Goldberg in an emotional open letter, the internet debated contracts, Hollywood politics, and accountability. But beneath the headlines lies a deeper conversation many women understand: the long shadow of mother wounds and how unresolved pain can shape how we experience conflict with other women. The Letter That Reopened Old Conversations In early 2026, Academy Award–winning actress Mo’Nique posted a public open letter to Whoopi Goldberg revisiting their tense exchange during Mo’Nique’s 2018 appearance on The View. The discussion originally centered around Mo’Nique’s claims that she was unfairly labeled “difficult” in Hollywood after the promotion of the film Precious. Mo’Nique maintains that she fulfilled the promotional requirements in her contract, while producers and industry leaders expecte...

Willpower or Wellness? Mo’Nique’s Warning on GLP-1 Weight Loss Drugs

Willpower or Wellness? Mo’Nique’s Warning on GLP-1 Weight Loss Drugs By Phatabulous Magazine When Mo’Nique speaks, she doesn’t whisper. She testifies. The Oscar-winning actress and comedian recently shared her concerns about the growing popularity of GLP-1 weight-loss drugs, questioning whether we are sacrificing something deeper than pounds on the scale. “What is the long-term effects? What will it do to your body? Your mind? What will it do to us five years from now, 10 years from now?” she asked in a heartfelt video. “They’re taking away our willpower. They’re taking away our fight.” Her message wasn’t just about medication. It was about autonomy. About discipline. About self-trust. And for many in the plus-size community, her words landed heavy. GLP-1 medications like Ozempic, Wegovy, and Mounjaro were originally developed to treat type 2 diabetes. They mimic a hormone that regulates blood sugar and appetite, helping people feel full faster and longer. In recent years, they’ve beco...